127 related articles for article (PubMed ID: 2422168)
1. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
Bannon MJ; Lee JM; Giraud P; Young A; Affolter HU; Bonner TI
J Biol Chem; 1986 May; 261(15):6640-2. PubMed ID: 2422168
[TBL] [Abstract][Full Text] [Related]
2. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
[TBL] [Abstract][Full Text] [Related]
3. Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists.
Bannon MJ; Elliott PJ; Bunney EB
Brain Res; 1987 Dec; 427(1):31-7. PubMed ID: 2448008
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
[TBL] [Abstract][Full Text] [Related]
5. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
Sivam SP; Krause JE; Takeuchi K; Li S; McGinty JF; Hong JS
J Pharmacol Exp Ther; 1989 Mar; 248(3):1297-301. PubMed ID: 2467980
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
Sivam SP
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
[TBL] [Abstract][Full Text] [Related]
7. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo.
Arenas E; Akerud P; Wong V; Boylan C; Persson H; Lindsay RM; Altar CA
Eur J Neurosci; 1996 Aug; 8(8):1707-17. PubMed ID: 8921261
[TBL] [Abstract][Full Text] [Related]
8. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A.
Krause JE; Chirgwin JM; Carter MS; Xu ZS; Hershey AD
Proc Natl Acad Sci U S A; 1987 Feb; 84(3):881-5. PubMed ID: 2433692
[TBL] [Abstract][Full Text] [Related]
9. Expression of substance P/neurokinin A-encoding preprotachykinin messenger ribonucleic acids in the rat enteric nervous system.
Sternini C; Anderson K; Frantz G; Krause JE; Brecha N
Gastroenterology; 1989 Aug; 97(2):348-56. PubMed ID: 2472998
[TBL] [Abstract][Full Text] [Related]
10. Tachykinins in the rat substantia nigra: effects of selective dopamine receptor antagonists.
Oblin A; Zivkovic B
Fundam Clin Pharmacol; 1991; 5(2):129-38. PubMed ID: 1712746
[TBL] [Abstract][Full Text] [Related]
11. Intranigral injection of selective neurokinin-1 and neurokinin-3 but not neurokinin-2 receptor agonists biphasically modulate striatal dopamine metabolism but not striatal preprotachykinin-A mRNA in the rat.
Humpel C; Saria A
Neurosci Lett; 1993 Jul; 157(2):223-6. PubMed ID: 7694197
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Sivam SP; Krause JE
J Neurochem; 1992 Dec; 59(6):2278-84. PubMed ID: 1279124
[TBL] [Abstract][Full Text] [Related]
13. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
[TBL] [Abstract][Full Text] [Related]
14. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
Lindefors N; Brodin E; Ungerstedt U
Eur J Pharmacol; 1989 Feb; 161(1):95-8. PubMed ID: 2470596
[TBL] [Abstract][Full Text] [Related]
15. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
Gresch PJ; Walker PD
Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
[TBL] [Abstract][Full Text] [Related]
16. The localization and characterization of substance P and substance K in striatonigral neurons.
Lee JM; McLean S; Maggio JE; Zamir N; Roth RH; Eskay RL; Bannon MJ
Brain Res; 1986 Apr; 371(1):152-4. PubMed ID: 2423184
[TBL] [Abstract][Full Text] [Related]
17. Changes in substance P concentrations after protein synthesis inhibition provide an index of substance P utilization.
Bannon MJ; Goedert M
Brain Res; 1984 May; 301(1):184-6. PubMed ID: 6203608
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing.
Nawa H; Kotani H; Nakanishi S
Nature; 1984 Dec 20-1985 Jan 2; 312(5996):729-34. PubMed ID: 6083453
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantitation of substance P-encoding preprotachykinin alternatively spliced mRNAs and substance P receptor NK-1 mRNA by an RNase protection assay.
Gautreau A; Kerdelhué B
Brain Res Brain Res Protoc; 1998 Jan; 2(2):133-40. PubMed ID: 9473630
[TBL] [Abstract][Full Text] [Related]
20. Regulation of striatonigral prodynorphin peptides by dopaminergic agents.
Trujillo KA; Day R; Akil H
Brain Res; 1990 Jun; 518(1-2):244-56. PubMed ID: 1975215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
